Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Zymeworks 股票：深入了解分析師觀點（5 個評級）
Ratings for Zymeworks (NASDAQ:ZYME) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，有5位分析師提供了Zymeworks（納斯達克股票代碼：ZYME）的評級，顯示了看漲和看跌的觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $12.4, a high estimate of $16.00, and a low estimate of $10.00. This current average has decreased by 2.75% from the previous average price target of $12.75.
分析師評估的12個月目標股價揭示了進一步的見解，平均目標價爲12.4美元，最高估計爲16.00美元，低估值爲10.00美元。目前的平均價格較之前的平均目標價12.75美元下降了2.75％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The analysis of recent analyst actions sheds light on...
對分析師最近行爲的...
登入免費觀看全文
登入/註冊